These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. Toska A; Modi N; Chen LF Cells; 2023 Feb; 12(5):. PubMed ID: 36899853 [TBL] [Abstract][Full Text] [Related]
43. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system. Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519 [TBL] [Abstract][Full Text] [Related]
44. The ubiquitin-proteasome system: focus on the heart. Zolk O; Schenke C; Sarikas A Cardiovasc Res; 2006 Jun; 70(3):410-21. PubMed ID: 16497285 [TBL] [Abstract][Full Text] [Related]
45. Ubiquitin-Proteasome System in ABA Signaling: From Perception to Action. Yu F; Wu Y; Xie Q Mol Plant; 2016 Jan; 9(1):21-33. PubMed ID: 26455462 [TBL] [Abstract][Full Text] [Related]
46. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif. Spencer ML; Theodosiou M; Noonan DJ J Biol Chem; 2004 Aug; 279(35):37069-78. PubMed ID: 15229225 [TBL] [Abstract][Full Text] [Related]
47. Comprehensive profiling of protein ubiquitination for drug discovery. Xu G; Jaffrey SR Curr Pharm Des; 2013; 19(18):3315-28. PubMed ID: 23151132 [TBL] [Abstract][Full Text] [Related]
48. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail. Mimoto R; Taira N; Takahashi H; Yamaguchi T; Okabe M; Uchida K; Miki Y; Yoshida K Cancer Lett; 2013 Oct; 339(2):214-25. PubMed ID: 23791882 [TBL] [Abstract][Full Text] [Related]
49. The role of aberrant proteolysis in lymphomagenesis. Sahasrabuddhe AA; Elenitoba-Johnson KS Curr Opin Hematol; 2015 Jul; 22(4):369-78. PubMed ID: 26049759 [TBL] [Abstract][Full Text] [Related]
50. Integration of multiple ubiquitin signals in proteasome regulation. Isasa M; Zuin A; Crosas B Methods Mol Biol; 2012; 910():337-70. PubMed ID: 22821603 [TBL] [Abstract][Full Text] [Related]
51. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma. Dong X; Han Y; Zhang E; Wang Y; Zhang P; Wang C; Zhong L; Li Q Aging (Albany NY); 2021 Apr; 13(7):10603-10618. PubMed ID: 33833131 [TBL] [Abstract][Full Text] [Related]
52. Targeting Deubiquitinating Enzymes and Autophagy in Cancer. Mooneyham A; Bazzaro M Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830 [TBL] [Abstract][Full Text] [Related]
54. Back to your heart: ubiquitin proteasome system-regulated signal transduction. Portbury AL; Ronnebaum SM; Zungu M; Patterson C; Willis MS J Mol Cell Cardiol; 2012 Mar; 52(3):526-37. PubMed ID: 22085703 [TBL] [Abstract][Full Text] [Related]
55. Ubiquitin-mediated regulation of TNFR1 signaling. Wertz IE; Dixit VM Cytokine Growth Factor Rev; 2008; 19(3-4):313-24. PubMed ID: 18515172 [TBL] [Abstract][Full Text] [Related]
56. ABA-dependent inhibition of the ubiquitin proteasome system during germination at high temperature in Arabidopsis. Chiu RS; Pan S; Zhao R; Gazzarrini S Plant J; 2016 Dec; 88(5):749-761. PubMed ID: 27496613 [TBL] [Abstract][Full Text] [Related]
57. Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis. Hamilton AM; Zito K Neural Plast; 2013; 2013():196848. PubMed ID: 23476809 [TBL] [Abstract][Full Text] [Related]
59. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Chen C; Sun X; Ran Q; Wilkinson KD; Murphy TJ; Simons JW; Dong JT Oncogene; 2005 May; 24(20):3319-27. PubMed ID: 15735697 [TBL] [Abstract][Full Text] [Related]
60. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome. Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]